ACV to Participate in the 4th Annual Needham Consumer Tech / Ecommerce Virtual Conference

BUFFALO, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the 4th Annual Needham Consumer Tech / Ecommerce Virtual Conference on Monday, November 25, 2024 at 11:00 am ET. […]

OraSure to Participate in Upcoming Investor Conference

BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session scheduled for 1 p.m. ET A live webcast and replay of the Q&A session will be

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the Winter 2024 Investor Summit Virtual on Thursday, November 21,

Codere Online Receives Delisting Notice from Nasdaq and Submits Appeal

Luxembourg, Grand Duchy of Luxembourg, November 18, 2024 – (GLOBE NEWSWIRE) Codere Online Luxembourg, S.A. (“Codere Online” or the “Company”) (Nasdaq: CDRO / CDROW), today announced that, on November 12, 2024, it received a staff determination letter (the “Letter”), from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company of

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

(NASDAQ:TERN), FOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Heather Turner, J.D., former Chief Executive Officer at Carmot Therapeutics, Inc., to

TOFUTTI ANNOUNCES UNAUDITED RESULTS FOR THE THIRTEEN AND TWENTY-SIX WEEKS ENDED JUNE 29, 2024

(Other OTC:TOFB),(OTC US:TOFB), Cranford, New Jersey, Nov. 18, 2024 (GLOBE NEWSWIRE) — TOFUTTI BRANDS INC. (OTCQX Symbol: TOFB) today announced its results for thirteen and thirty-nine weeks ended September 28, 2024. Tofutti Brands reported that net sales for the thirteen weeks ended September 28, 2024 decreased by $529,000, or 21%, to $1,986,000, from net sales

FormFactor Receives SK hynix Best Partner Award

(NASDAQ:FORM), LIVERMORE, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading supplier of electrical test and measurement solutions for the semiconductor industry, announced today that it has been recognized as an outstanding partner by SK hynix, a global leader in DRAM and Flash memory manufacturing. The award honors FormFactor for its

ACV to Participate in the 4th Annual Needham Consumer Tech / Ecommerce Virtual Conference

(NASDAQ:ACVA), BUFFALO, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the 4th Annual Needham Consumer Tech / Ecommerce Virtual Conference on Monday, November 25, 2024 at 11:00 am

OraSure to Participate in Upcoming Investor Conference

(NASDAQ:OSUR), BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session scheduled for 1 p.m. ET A live webcast and replay of the Q&A session will

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

(NASDAQ:TNXP), CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the Winter 2024 Investor Summit Virtual on Thursday, November

Scroll to Top